Silver Book Fact

Greater use of clot-busting drug t-PA in ischemic
stroke patients could save the health care system
over $100 million a year.

New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life. http://www.ninds.nih.gov/news_and_events/press_releases/pressrelease_stroke_treatment_042298.htm. Published 21-Apr-1998

Reference

Title
New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life
Publication Date
Published 21-Apr-1998
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Death rates from heart disease and stroke are falling in-part because of new drug treatments. According to the National Heart, Lung and Blood Institute, if death rates were the same…  
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • Following the current path, pulmonary condition cases will increase by 31.3% between 2003 and 2023. If an alternative path is taken, there will be 9.1% fewer pulmonary condition cases.  
  • Beta-Blocker Treatment After A Heart Attack: Trends, 1996-2006  
  • Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.